Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 19 February 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

High mortality with refractory ascites and Hep C recurrence

Mortality rates were higher following refractory ascites development while it was ongoing, and survival was poorer among patients having bacterial peritonitis or Hep C virus recurrence, finds January's American Journal of Transplantation.

News image

fiogf49gjkf04

Dr Nishidaa and colleagues retrospectively studied 1058 liver transplant recipients.

The researchers determined the incidence, etiology, timing, clinical features and treatment of refractory ascites.

The team also assessed risk factors for refractory ascites development, and predictors of refractory ascites disappearance.

In addition, the researchers evaluated predictors of survival following refractory ascites, and the impact of refractory ascites on patient survival.

The team noted that 62 patients developed refractory ascites, and its disappearance occurred in 27 of these 62 cases.

Patients having Hepatitis C virus had a significantly higher hazard rate of developing refractory ascites.

The team found no other baseline characteristic associated with refractory ascites.

Mortality rates were nearly 9 higher following refractory ascites development
American Journal of Transplantation

Cox stepwise regression analysis of the hazard rate of refractory ascites disappearance found 2 significant factors.

Using this analysis, Hepatitis C virus recurrence as the reason for developing refractory ascites was shown to result in a poorer outcome.

The researchers observed that an unknown reason for developing refractory ascites implied a favorable outcome.

Survival following refractory ascites was significantly poorer among patients having bacterial peritonitis or Hepatitis C virus recurrence.

Finally, the team noted that the mortality rate was nearly 9 higher in patients following refractory ascites development while it was ongoing.

However, the researchers found that if the refractory ascites disappeared, then the additional risk of death also disappeared.

Dr Nishidaa's team concluded, “This study illustrates the importance of developing an optimal treatment strategy.”

“Such a treatment strategy should effectively treat refractory ascites if it develops and also prevent Hepatitis C recurrence.”

Am J Transpl 2006: 6(1): 140
09 January 2006

Go to top of page Email this page Email this page to a colleague

 17 February 2017 
Genetic mutations predict esophageal cancer
 17 February 2017 
Anesthesia services during outpatient gastroenterology procedures
 17 February 2017 
Genetic mutations predict esophageal cancer
 16 February 2017 
Hysterectomy and pelvic floor disorders
 16 February 2017 
Anesthetist-directed sedation in endoscopic procedures
 16 February 2017 
Assisted reproduction in women with IBD 
 15 February 2017 
Metal stents for palliation in malignant biliary obstruction
 15 February 2017 
Hepatocellular carcinoma in the USA
 15 February 2017 
Increasing screening of cirrhosis in hepatocellular carcinoma
 14 February 2017 
Pathologists agreement in the diagnosis of Barrett's
 14 February 2017 
Preventive care in IBD 
 14 February 2017 
Infliximab dose for acute severe ulcerative colitis
 13 February 2017 
Vasoactive drugs for hepatorenal syndrome type 1
 13 February 2017 
Pregnancy outcomes after endoscopy
 13 February 2017 
H. pylori treatment guidelines
 10 February 2017 
Primary ileocecal resection in pediatric Crohn's disease
 10 February 2017 
Non-adherence in end-stage liver disease
 10 February 2017 
Isolated colonic Crohn's disease
 09 February 2017 
Mucosal healing in ulcerative colitis
 09 February 2017 
NAFLD and coronary artery calcium score
 09 February 2017 
Prevalence of Hep D in chronic Hep B infection
 08 February 2017 
Rifaximin for small intestine bacterial overgrowth
 08 February 2017 
Risk prediction of interval cancers from inadequate colonoscopy quality
 08 February 2017 
Meta-analyses in gastroenterology and hepatology journals
 07 February 2017 
Chemoprevention in colon cancer
 07 February 2017 
Methotrexate intolerance in pediatric IBD 
 07 February 2017 
Untreated hepatocellular carcinoma in the USA
 06 February 2017 
Vitamin D levels and risk of relapse in ulcerative colitis
 06 February 2017 
Giardia in the USA
 06 February 2017 
Colorectal cancer risk in serrated polyposis syndrome
 03 February 2017 
Helicobacter and Campylobacter in IBD
 03 February 2017 
Mortality risk in elderly-onset IBD
 03 February 2017 
Management of chronic refractory pouchitis
 02 February 2017 
IBD-related research and publications
 02 February 2017 
TWEAK in IBD
 02 February 2017 
Clostridium difficile and colectomy risk in IBD
 01 February 2017 
Suboptimal bowel preparation in outpatient colonoscopy
 01 February 2017 
Fecal microbiota transplantation
 01 February 2017 
Socio-economic distribution of IBD 
 31 January 2017 
Gastroenterology fellowship
 31 January 2017 
Approach to Lynch syndrome
 31 January 2017 
Fat intake and ulcerative colitis risk
 30 January 2017 
Dietary risk of acute pancreatitis
 30 January 2017 
Care pathway for anemia in IBD 
 30 January 2017 
Mortality in elderly-onset IBD
 27 January 2017 
Cancer mortality in the USA
 27 January 2017 
Therapeutic drug monitoring in IBD 
 27 January 2017 
Monoclonal antibodies for recurrent C. diff
 26 January 2017 
Propofol for gastrointestinal endoscopy
 26 January 2017 
Therapy in pediatric IBD
 26 January 2017 
Disease knowledge in adolescents with IBD
 24 January 2017 
Course of achalasia
 24 January 2017 
H. pylori and iron deficiency anemia
 24 January 2017 
Hospital transfer and colorectal surgery
 23 January 2017 
Diagnosis of pancreatic cancer
 23 January 2017 
Care pathway for anemia in IBD 
 23 January 2017 
Fatigue in IBD after diagnosis
 20 January 2017 
Predictors of small bowel Crohn's in capsule endoscopy
 20 January 2017 
Stool output after a meal
 20 January 2017 
Abnormalities in functional dyspepsia

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us